LDB2 and lung adenocarcinoma: High expression levels of WARS were found in high microsatellite-instable gastrointestinal adenocarcinomas, associated with poor prognosis [32], while a decreased expression of LDB2 was associated with a more favorable outcome in lung adenocarcinoma patients [33].